Analyst Research: Threshold Pharmaceuticals Inc (THLD.O)

THLD.O on Consolidated Issue listed on NASDAQ Capital Market

3.96USD
2 Jul 2015
Change (% chg)

$0.07 (+1.80%)
Prev Close
$3.89
Open
$3.86
Day's High
$3.98
Day's Low
$3.86
Volume
428,425
Avg. Vol
653,718
52-wk High
$5.41
52-wk Low
$2.58

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
THLD: Due Diligence Review: Forensic Earnings and Valuation 2 Jul 2015 New Constructs, LLC 10 25.00
Thomson Reuters Stock Report - Threshold Pharmaceuticals Inc (THLD-O) 1 Jul 2015 Thomson Reuters Stock Report 11 25.00
Value Graph: THRESHOLD PHARMA -- THLD 1 Jul 2015 Ford Investor Services, Inc. 1 12.00
ValuEngine Industry Report for Medical-biomed/genetics(THLD) 30 Jun 2015 ValuEngine, Inc. 10 49.00
Wright Investors Service Comprehensive Report for Threshold Pharmaceuticals, Inc. 28 Jun 2015 Wright Reports 56 75.00
Threshold Pharmaceuticals 27 Jun 2015 S&P Capital IQ Quantitative Report 10 115.00
THRESHOLD PHARMACEUTICALS INC (THLD) 12-months forecast 26 Jun 2015 Pechala's Reports 1 15.00
Threshold Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 26 Jun 2015 Reuters Investment Profile 12 20.00
TheStreet.com Ratings Stock Report For: THRESHOLD PHARMACEUTICALS (THLD) 20 Jun 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Harold Selick

59 Chief Executive Officer, Director

Stewart Kroll

56 2014 Senior Vice President, Clinical Development

Robert Simon

70 2012 Senior Vice President - Regulatory Affairs and Quality Assurance

Joel Fernandes

45 2011 Vice President - Finance, Controller

Nipun Davar

47 2011 Vice President - Pharmaceutical Development and Manufacturing
Search Stocks